Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir in hospitalized COVID-19 patients
NCT04373733Phase 3Completed
- Sponsor
- Chelsea and Westminster Hospital NHS Foundation Trust
- Start
- May 2020
- Primary completion
- Jun 2021
- Countries
- 3
01
Overview
A Phase 3 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Chelsea and Westminster Hospital NHS Foundation Trust. Started May 2020; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04373733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373733.